CStone Pharmaceuticals advances cancer research with first-in-human clinical trial application for CS2009

Pallavi Madhiraju- December 23, 2024 0

CStone Pharmaceuticals, an innovation-driven biopharmaceutical company listed on the Hong Kong Stock Exchange (HKEX: 2616), has taken a significant step forward in its mission to ... Read More

Hanmi Pharmaceutical, Beijing Hanmi progress cancer therapy BH3120 with promising trial results

Pallavi Madhiraju- November 25, 2024 0

Hanmi Pharmaceutical and Beijing Hanmi Pharmaceutical are making significant strides in the development of BH3120, a next-generation cancer immunotherapy. Updates on the innovative treatment were ... Read More

Biotech breakthrough: Mersana Therapeutics stock soars 23% after blowing past Q3 expectations

Pallavi Madhiraju- November 13, 2024 0

Mersana Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) for cancer treatment, saw its shares leap by 23% following a robust ... Read More